Reanalysis

For Health Providers > Reanalysis

Genomic science is moving at an extraordinary pace. New disease-gene associations are discovered, clinical guidelines are updated, and variant databases grow richer every month. A genetic test that comes back today as “no findings” or “variants of uncertain significance” may look completely different in a year or two. Reanalysis takes advantage of this expanding knowledge base by revisiting an individual’s genomic data to uncover insights that were not possible at the time of the original report. This can lead to new diagnoses, refined risk assessments, and improved clinical care without the need for another sample or new sequencing.

Whole genome sequencing (WGS) is uniquely powerful for reanalysis because it captures all of an individual’s genetic information, not just a panel of selected genes. As new conditions, pathways, or biomarkers are linked to genetic variation, existing WGS data can be re-examined to generate fresh answers. Unlike targeted tests, which are limited to a predefined scope, WGS ensures that no additional sequencing is needed—the data is already there, waiting to be mined with updated tools, methods, and scientific understanding. This means that WGS is not a one-off test, but a lifelong resource, enabling clinicians and patients to benefit continuously from advances in genomic science.

For research institutes and organisations holding large genomic datasets, this means there are often untapped insights waiting to be discovered.

Our reanalysis service makes this process effortless. Simply upload your existing datasets — whether you’re working with 200 patients or more — and tell us which regions or conditions you’d like us to focus on. We’ll handle everything from secure data formatting and storage, through to running bespoke analyses and generating comprehensive reports.

To keep your research current, we can establish a reanalysis cycle every 3 or 6 months. Each cycle incorporates the latest scientific knowledge, variant classifications, and databases, ensuring your results evolve alongside the science. You’ll receive both detailed reports and high-level summaries, along with clear feedback on any new findings of importance.

By outsourcing the complexity of genomic reanalysis to us, your team can focus on the science and clinical applications, while we ensure your datasets continue to deliver value long after the initial sequencing.